A Chance to Disrupt the Clinic-Based Dialysis Market

A Chance to Disrupt the Clinic-Based Dialysis Market; image of a a patient receiving dialysis.In a move that eventually could disrupt the dialysis market, CVS Health recently began a trial for its HemoCare device to determine whether it is more convenient and effective than clinic-based treatment. HemoCare uses an artificial kidney device to simplify dialysis for home-based patients.

The connected health platform will be tested in a study involving 70 patients across multiple clinic sites before the company seeks Food and Drug Administration approval to move to the home market. The move comes just weeks after the Trump administration issued an executive order to improve treatment for end-stage renal disease patients and to educate the public on ways to improve health and wellness and to prevent kidney-related health issues.

CVS Health hopes that HemoCare will enhance kidney care, since clinical research has linked improved patient outcomes with longer treatments provided in the home. The company also is working to bring early detection solutions for kidney disease and provide education and support to help delay the transition to dialysis.

Fresenius Medical Care and DaVita, which currently dominate the dialysis market with more than 5,000 dialysis clinics in the U.S., are certain to closely monitor results of the CVS Health pilot. In late February, Fresenius spent close to $2 billion on its acquisition of NxStage, a maker of home-use dialysis machines and critical care products. The company also said it would plan to convert some of its dialysis clinics into transitional care units to train people for home care. DaVita also offers remote monitoring and telehealth technology to improve the patient care dialysis experience at home.

Related Resources

AHA Center for Health Innovation Market Scan
With ever-increasing frequency, hospitals and health systems are establishing or expanding venture funds in search of the next startup that could revolutionize…
Calls
Member
Listen to the Home Health Advisory Call - August 15, 2019. 
AHA Center for Health Innovation Market Scan
Aurora, Colo.-based UCHealth has deployed Avaamo’s conversational artificial intelligence platform to create a virtual assistant called Livi that will enable…
Presentation Resource
Member
AHA Center for Health Innovation Market Scan
Health care’s thought leaders, innovators and doers recently convened at the AHA Leadership Summit in San Diego. They explored innovation processes and…
Feature
Health care’s leading thinkers, innovators and doers recently convened at the AHA Leadership Summit in San Diego. They explored innovation processes and…